title: Mutagenic specificity of imidazole ring-opened 7-methylpurines in M13mp18 phage DNA.
abstract: The most abundant lesion formed in DNA upon modification with methylating agents 7-methylguanine, under alkaline conditions is converted into 2,6-diamino-4-hydroxy-5N-methyl-formamidopyrimidine (Fapy-7MeGua). We have previously shown that treatment of dimethylsulfate methylated DNA with NaOH creates mutagenic base derivatives leading to a 60-fold increase in the frequency of A-->G transitions and a 2-3-fold increase of G-->T and G-->C transversions. We have analyzed which lesions lead to these mutations. We compared mutagenic spectra in the lacZ gene of M13mp18 phage DNA modified with dimethylsulfate and NaOH after selective elimination of damaged bases from molecules used for transfection into SOS-induced E. coli. Partial elimination of Fapy-7MeGua from phage DNA performed by its digestion with formamidopyrimidine-DNA glycosylase resulted in a 2-3-fold decrease of G-->T and G-->C transversions. Selective depurination of methylated bases (9 h, 37 degrees C, pH 7.0) resulting in almost complete loss of 7MeAde as demonstrated by HPLC analysis of [3H]MNU alkylated phage DNA used as a probe, caused a dramatic, 9-fold decrease of A-->G transitions. Alkali-catalysed rearrangement of 7MeAde was followed by HPLC analysis of [3H]MNU alkylated poly(A) and poly(dA). After incubation of these oligonucleotides in NaOH, 7MeAde disappeared from both chromatograms, but only in polyA, 2 new peaks migrating with retention time different from that of 1MeAde, 3MeAde or 7MeAde were detected, suggesting formation of two rotameric forms of Fapy-7MeAde as observed for Fapy-7MeGua. Thus the miscoding lesion, giving rise to A-->G transitions derived from 7MeAde was Fapy-7MeAde. Fapy-7MeGua was at least an order of magnitude less mutagenic, but in SOS-induced cells it gave rise to G-->T and G-->C transversions.
authors.affiliation: Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa. tudek@ibbrain.ibb.waw.pl
authors.forename: B
authors.initials: B
authors.lastname: Tudek
authors.forename: M
authors.initials: M
authors.lastname: Graziewicz
authors.forename: O
authors.initials: O
authors.lastname: Kazanova
authors.forename: T H
authors.initials: TH
authors.lastname: Zastawny
authors.forename: T
authors.initials: T
authors.lastname: Obtułowicz
authors.forename: J
authors.initials: J
authors.lastname: Laval
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000633:toxicity; D001483:Base Sequence; D004249:DNA Damage; D019175:DNA Methylation; D004279:DNA, Viral / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics*; D043382:DNA-Formamidopyrimidine Glycosylase; D004926:Escherichia coli / Q000235:genetics; D029968:Escherichia coli Proteins; D006147:Guanine / Q000031:analogs & derivatives* / Q000633:toxicity; D007093:Imidazoles / Q000737:chemistry; D007763:Lac Operon; D008969:Molecular Sequence Data; D009153:Mutagens / Q000633:toxicity*; D009154:Mutation; D009699:N-Glycosyl Hydrolases / Q000378:metabolism; D011743:Pyrimidines / Q000737:chemistry; D014162:Transfection
chemical_list: D004279:DNA, Viral; D029968:Escherichia coli Proteins; D007093:Imidazoles; D009153:Mutagens; D011743:Pyrimidines; C071023:2,6-diamino-4-hydroxy-5-formamidopyrimidine; C039544:4,6-diamino-5-N-formamidopyrimidine; D006147:Guanine; C008450:7-methylguanine; C059225:7-methyladenine; D009699:N-Glycosyl Hydrolases; D043382:DNA-Formamidopyrimidine Glycosylase; C468610:DNA-formamidopyrimidine glycosylase, E coli; D000225:Adenine